Free Trial
→ Analyst nicknamed “The Prophet” issues new warning for America (From Stansberry Research) (Ad)tc pixel
NASDAQ:NEPH

Nephros Q3 2026 Earnings Date & Estimates

Nephros logo
$3.53 +0.24 (+7.29%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$3.53 0.00 (0.00%)
As of 10/9/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nephros is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Nephros in Q3 2026

Nephros is expected to post earnings of $0.02 per share on revenue of $5.49 million. In the same quarter a year earlier Nephros reported $0.03 per share on revenue of $4.76 million. Nephros last reported on August 6, 2026, posting $0.06 per share and beating the $0.0033 consensus estimate. Nephros has beaten the consensus EPS estimate in 5 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.02
Expected Revenue
$5.49 million
Prior-Year EPS
$0.03
Prior-Year Revenue
$4.76 million
Expected EPS Growth
-33.3%
Expected Revenue Growth
+15.3%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.06 (Beat by +$0.0567)
Last Quarter Revenue
$6.02 million
EPS Beat Rate
5 of last 8 quarters

Prepare for the Q3 2026 Call

Nephros Q3 2026 Earnings FAQ

Nephros (NASDAQ:NEPH) is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes.

Nephros' Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Nephros to post earnings of $0.02 per share for Q3 2026.

The consensus revenue estimate for Nephros is $5.49 million for Q3 2026.

Nephros Earnings Headlines

Nephros (NASDAQ:NEPH) and TransMedics Group (NASDAQ:TMDX) Critical Analysis
October 1, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31072964
Nephros (NEPH) Q2 2026 Earnings Call Transcript
August 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/nephros-neph-q2-2026-earnings-114257498.html
What’s Elon building now?
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and built in a matter of weeks. James Altucher says the site could go live as soon as October 21 and has put together a free presentation explaining what is happening inside and why the timing matters.tc pixel
October 10 at 1:00 AM  |  Paradigm Press (Ad)
Nephros details integrated water safety platform while expanding in Greater New York and Puerto Rico
August 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4628653-nephros-details-integrated-water-safety-platform-while-expanding-in-greater-new-york-and
Nephros, Inc. (NEPH) Q2 2026 Earnings Call Transcript
August 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4932488-nephros-inc-neph-q2-2026-earnings-call-transcript
Nephros Schedules Second Quarter 2026 Financial Results Conference Call
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339622/0/en/nephros-schedules-second-quarter-2026-financial-results-conference-call.html
See More Nephros Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nephros? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nephros and other key companies, straight to your email.

About Nephros

Nephros (NASDAQ:NEPH), Inc. is a medical device company that develops and sells filtration products for healthcare and commercial applications. Its primary focus is point-of-use water filtration systems designed to help reduce bacteria, including waterborne pathogens such as Legionella, in hospitals, long-term care facilities, and other healthcare settings.

The company’s product portfolio includes disposable and durable water filtration systems intended for use at sinks, showers, and other water outlets. Nephros also has a history of developing ultrafiltration products for blood purification and hemodialysis applications, although its business has increasingly emphasized water filtration solutions.

Nephros serves customers primarily in the United States through healthcare providers, distributors, and commercial partners. Its products are used in settings where water quality and infection-control practices are important, including hospitals, nursing facilities, and other institutional environments.

View Nephros Profile
Earnings Tools